Microkeratome Market, By Product (Reusable and Disposable), By Treatment (Retinal Detachment, Diabetic Retinopathy, Epiretinal Membrane, and Others), By End User (Hospitals, Ophthalmic Centers, and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jul 2023

Code : CMI3965

Pages :160

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Microkeratome Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global microkeratome market over the forecast period. North America is estimated to hold 42.5% of the market share. The North America microkeratome market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of eye disorders such as glaucoma, refractive error, cataracts, and increase in the geriatric population. For instance, in December 2022, according to Centers for Disease Control and Prevention, as of 2020, 4.2 million people in the U.S. aged 40 years and older suffer from uncorrectable vision impairment, out of which 1.02 million who are blind; this number is predicted to more than double by 2050 to 8.96 million due to the increasing epidemics of diabetes and other chronic diseases and our rapidly aging population in the U.S.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa